Piperidine derivatives, their preparation and their therapeutic
application
    51.
    发明授权
    Piperidine derivatives, their preparation and their therapeutic application 失效
    哌啶衍生物,其制备及其治疗应用

    公开(公告)号:US5280030A

    公开(公告)日:1994-01-18

    申请号:US862376

    申请日:1992-04-02

    摘要: A compound which is a piperidine derivative of general formula (I) ##STR1## in which R.sub.1 represents a hydrogen atom, a linear or branched (C.sub.1-6)alkyl group or a cyclo(C.sub.3-8)alkyl group, X represents an oxygen atom, a sulphur atom or a group of general formula N--R.sub.3 in which R.sub.3 is a hydrogen atom, or a linear or branched (C.sub.1-8)alkyl, cyclo(C.sub.3-6)alkyl, cyclo(C.sub.3-6)alkylmethyl, (C.sub.1-4)alkoxy-(C.sub.1-4)alkyl, phenyl, pyridin-4-yl, pyridin-3-yl, pyridin-4-ylmethyl or pyridin-3-ylmethyl group and Z represents a hydrogen or fluorine atom and acid addition salts thereof with pharmaceutically acceptable acids, can be used for the treatment and prevention of disorders in which 5-HT receptors are involved.

    摘要翻译: 对应于通式(I)的化合物,其中R 1表示氢原子或直链或支链(C 1-6)烷基或环(C 3-8)烷基,X表示 氧原子或硫原子或其中R3是氢原子的通式为N-R3的基团,直链或支链(C1-8)烷基,环(C3-6)烷基,环(C3 -6)烷基甲基,(C 1-4)烷氧基(C 1-4)烷基,苯基,4-吡啶基或3-吡啶基,Z表示氢或氟原子,以及它们的加成盐 与药学上可接受的酸。 应用于治疗。